[Federal Register Volume 78, Number 66 (Friday, April 5, 2013)]
[Notices]
[Page 20647]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-08032]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Public Meeting of the Presidential Commission for the Study of 
Bioethical Issues

AGENCY: Presidential Commission for the Study of Bioethical Issues, 
Office of the Assistant Secretary for Health, Department of Health and 
Human Services.

ACTION: Notice of Meeting.

-----------------------------------------------------------------------

SUMMARY: The Presidential Commission for the Study of Bioethical Issues 
will conduct its thirteenth meeting on April 30, 2013. At this meeting, 
the Commission will discuss the ethical implications of incidental 
findings.

DATES: The meeting will take place Tuesday, April 30, 2013.

ADDRESSES: The Hamilton Crowne Plaza Hotel, 1001 14th St. NW., 
Washington, DC 20005. Telephone (202) 682-0111.

FOR FURTHER INFORMATION CONTACT: Hillary Wicai Viers, Communications 
Director, Presidential Commission for the Study of Bioethical Issues, 
1425 New York Avenue NW, Suite C-100, Washington, DC 20005. Telephone: 
202-233-3960. Email: [email protected]. Additional 
information may be obtained at www.bioethics.gov.

SUPPLEMENTARY INFORMATION: Pursuant to the Federal Advisory Committee 
Act of 1972, Public Law 92-463, 5 U.S.C. app. 2, notice is hereby given 
of the thirteenth meeting of the Presidential Commission for the Study 
of Bioethical Issues (the Bioethics Commission). The meeting will be 
held from 9:00 a.m. to approximately 5:15 p.m. on Tuesday, April 30, 
2013, in Washington, DC The meeting will be open to the public with 
attendance limited to space available. The meeting will also be webcast 
at www.bioethics.gov.
    Under authority of Executive Order 13521, dated November 24, 2009, 
the President established the Bioethics Commission. The Bioethics 
Commission is an advisory panel of the nation's leaders in medicine, 
science, ethics, religion, law, and engineering. The Bioethics 
Commission advises the President on bioethical issues arising from 
advances in biomedicine and related areas of science and technology. 
The Bioethics Commission seeks to identify and promote policies and 
practices that ensure scientific research, health care delivery, and 
technological innovation are conducted in a socially and ethically 
responsible manner.
    The main agenda item for the Bioethics Commission's thirteenth 
meeting is to discuss the ethical implications of incidental findings.
    The draft meeting agenda and other information about the Bioethics 
Commission, including information about access to the webcast, will be 
available at www.bioethics.gov.
    The Bioethics Commission welcomes input from anyone wishing to 
provide public comment on any issue before it. Respectful debate of 
opposing views and active participation by citizens in public exchange 
of ideas enhances overall public understanding of the issues at hand 
and conclusions reached by the Bioethics Commission. The Bioethics 
Commission is particularly interested in receiving comments and 
questions during the meeting that are responsive to specific sessions. 
Written comments will be accepted at the registration desk and comment 
forms will be provided to members of the public in order to write down 
questions and comments for the Bioethics Commission as they arise. To 
accommodate as many individuals as possible, the time for each question 
or comment may be limited. If the number of individuals wishing to pose 
a question or make a comment is greater than can reasonably be 
accommodated during the scheduled meeting, the Bioethics Commission may 
make a random selection.
    Anyone planning to attend the meeting who needs special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should notify Esther Yoo by telephone at (202) 233-
3960, or email at [email protected] in advance of the meeting. 
The Bioethics Commission will make every effort to accommodate persons 
who need special assistance.
    Written comments will also be accepted in advance of the meeting 
and are especially welcome. Please address written comments by email to 
[email protected], or by mail to the following address: Public 
Commentary, Presidential Commission for the Study of Bioethical Issues, 
1425 New York Ave., NW., Suite C-100, Washington, DC 20005. Comments 
will be publicly available, including any personally identifiable or 
confidential business information that they contain. Trade secrets 
should not be submitted.

    Dated: March 21, 2013.
Lisa M. Lee,
Executive Director, Presidential Commission for the Study of Bioethical 
Issues.
[FR Doc. 2013-08032 Filed 4-4-13; 8:45 am]
BILLING CODE 4154-06-P